Acetyl-CoA Carboxylase Inhibitor GS-0976 Leads to Significant Improvements in MRI-PDFF in a Phase 2, Randomized, Placebo-Controlled Trial of Patients with NASH

Media coverage

• Title	Acetyl-CoA Carboxylase Inhibitor GS-0976 Leads to Significant Improvements in MRI-PDFF in a Phase 2, Randomized, Placebo-Controlled Trial of Patients with NASH
  Media name/outlet	National AIDS Treatment Advocacy Project
  Country	United States
  Date	10/27/17
  Persons	Eric J Lawitz